Clinical trial
Hummingbird ICE Study
NCT07552272 is registered in ClinicalTrials.gov with Philips Clinical & Medical Affairs Global as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hummingbird ICE Study
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2031
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atrial appendage closure for atrial fibrillation, atrial fibrillation (af), atrial septal defect, patent foramen ovale, tricuspid valve disease, valve disease, heart